Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 53

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection

Alhariri, Moayad, Omri, Abdelwahab·2013·Antimicrobial Agents and Chemotherapy

Abstract

We sought to investigate alterations in quorum-sensing signal molecule N -acyl homoserine lactone secretion and in the release of Pseudomonas aeruginosa virulence factors, as well as the in vivo antimicrobial activity of bismuth-ethanedithiol incorporated into a liposome-loaded tobramycin formulation (LipoBiEDT-TOB) administered to rats chronically infected with P. aeruginosa . The quorum-sensing signal molecule N -acyl homoserine lactone was monitored by using a biosensor organism. P. aeruginosa virulence factors were assessed spectrophotometrically. An agar beads model of chronic Pseudomonas lung infection in rats was used to evaluate the efficacy of the liposomal formulation in the reduction of bacterial count. The levels of active tobramycin in the lungs and the kidneys were evaluated by microbiological assay. LipoBiEDT-TOB was effective in disrupting both quorum-sensing signal molecules N -3-oxo-dodeccanoylhomoserine lactone and N -butanoylhomoserine lactone, as well as significantly ( P < 0.05) reducing lipase, chitinase, and protease production. At 24 h after 3 treatments, the CFU counts in lungs of animals treated with LipoBiEDT-TOB were of 3 log 10 CFU/lung, comparated to 7.4 and 4.7 log 10 CFU/lung, respectively, in untreated lungs and in lungs treated with free antibiotic. The antibiotic concentration after the last dose of LipoBiEDT-TOB was 25.1 μg/lung, while no tobramycin was detected in the kidneys. As for the free antibiotic, we found 6.5 μg/kidney but could not detect any tobramycin in the lungs. Taken together, LipoBiEDT-TOB reduced the production of quorum-sensing molecules and virulence factors and could highly improve the management of chronic pulmonary infection in cystic fibrosis patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.01634-12

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 77

  1. 10.4187/aarc0443 · DOI
  2. 10.4187/aarc0446 · DOI
  3. 10.1097/MCP.0b013e32833f1d00 · DOI
  4. 10.1074/jbc.M505832200 · DOI · Paper page
  5. 10.1258/la.2007.06014e · DOI
  6. 10.1074/jbc.272.22.14037 · DOI · Paper page
  7. 10.1016/j.ijmm.2011.08.003 · DOI
  8. 10.1128/CMR.00068-09 · DOI · Paper page
  9. 10.1111/j.1469-0691.2011.03742.x · DOI
  10. 10.1002/ppul.10127 · DOI · Paper page
  11. 10.3389/fmicb.2011.00162 · DOI
  12. 10.1128/aem.60.6.1734-1738.1994 · DOI · Paper page
  13. 10.1097/QCO.0b013e32834748ff · DOI
  14. 10.1165/ajrcmb.19.2.2889 · DOI
  15. 10.1111/j.1365-2958.2005.05002.x · DOI · Paper page
  16. 10.1152/ajplung.00383.2001 · DOI · Paper page
  17. 10.1165/ajrcmb.19.6.3194 · DOI
  18. 10.1186/1471-2180-7-45 · DOI · Paper page
  19. 10.1128/JB.00007-07 · doi:10.1128/jb.00007-07
  20. 10.1557/mrs.2011.67 · DOI
  21. 10.1099/mic.0.028464-0 · doi:10.1099/mic.0.028464-0
  22. 10.1371/journal.pone.0010115 · DOI · Paper page
  23. 10.1093/emboj/cdg366 · DOI · Paper page
  24. 10.1128/JB.185.7.2066-2079.2003 · DOI · Paper page
  25. 10.1128/JB.183.24.7044-7052.2001 · DOI
  26. 10.1128/JB.186.10.2936-2945.2004 · DOI
  27. 10.1128/JB.00409-06 · DOI · Paper page
  28. 10.1099/mic.0.25967-0 · DOI
  29. 10.1073/pnas.92.20.9427 · DOI · Paper page
  30. 10.1042/BST0370863 · DOI
  31. 10.1002/ppul.20735 · DOI
  32. 10.4187/002013209790983241 · doi:10.4187/002013209790983241
  33. 10.1016/j.jcf.2009.08.004 · DOI
  34. 10.1016/j.jcf.2010.09.003 · doi:10.1016/j.jcf.2010.09.003
  35. 10.1056/NEJM199607183350307 · DOI · Paper page
  36. 10.1186/1471-2334-10-148 · DOI
  37. 10.1080/00313020400011300 · doi:10.1080/00313020400011300
  38. 10.1128/AAC.39.1.34 · DOI
  39. KhanW BernierSP KuchmaSL HammondJH HasanF O'TooleGA. 2010. Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide. Int. Microbiol. 13:207–212.
  40. 10.1097/MCP.0b013e32833eebfd · DOI
  41. 10.1128/JB.01655-07 · DOI · Paper page
  42. 10.1093/jac/43.5.659 · doi:10.1093/jac/43.5.659
  43. 10.1128/AAC.41.8.1697 · doi:10.1128/aac.41.8.1697
  44. 10.1093/jac/44.5.601 · doi:10.1093/jac/44.5.601
  45. 10.1007/BF01967072 · doi:10.1007/bf01967072
  46. 10.1093/jac/dkg471 · doi:10.1093/jac/dkg471
  47. 10.1165/ajrcmb.26.6.2001-00020oc · doi:10.1165/ajrcmb.26.6.2001-00020oc
  48. 10.1093/jac/dkp165 · DOI · Paper page
  49. 10.2174/092986709789712916 · DOI
  50. 10.1016/j.ijpharm.2008.03.008 · DOI
  51. 10.1016/j.ijpharm.2009.02.001 · doi:10.1016/j.ijpharm.2009.02.001
  52. 10.1016/j.mimet.2004.04.016 · DOI · Paper page
  53. 10.1099/0022-1317-51-12-1063 · DOI
  54. MillerJH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  55. CashHA WoodsDE McCulloughB JohansonWGJr BassJA. 1979. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 119:453–459.
  56. 10.1128/AAC.38.5.1090 · DOI
  57. 10.1136/thx.2009.121657 · DOI · Paper page
  58. 10.1016/j.ijpharm.2007.11.035 · DOI
  59. 10.1093/jac/dkm289 · DOI
  60. 10.1111/j.1523-5378.2011.00857.x · DOI
  61. 10.1111/j.2042-7158.2011.01304.x · doi:10.1111/j.2042-7158.2011.01304.x
  62. 10.1158/1940-6207.CAPR-08-0237 · doi:10.1158/1940-6207.capr-08-0237
  63. 10.1080/10611860802201134 · DOI
  64. 10.1093/jac/dkg317 · DOI
  65. 10.1007/s11095-008-9755-4 · DOI · Paper page
  66. 10.1093/jac/dkn059 · DOI · Paper page
  67. 10.1016/j.ijpharm.2005.10.005 · DOI
  68. 10.1016/j.bbamem.2003.11.016 · DOI
  69. 10.3109/02652049309015314 · DOI
  70. HorrevortsAM DriessenOM MichelMF KerrebijnKF. 1988. Pharmacokinetics of antimicrobial drugs in cystic fibrosis: aminoglycoside antibiotics. Chest 94:120S–125S.
  71. 10.1128/AAC.40.3.665 · DOI
  72. 10.1016/S0006-2952(02)01346-1 · DOI · Paper page
  73. 10.1007/s12325-008-0105-2 · DOI
  74. 10.1186/cc2415 · DOI
  75. 10.1172/JCI116196 · DOI
  76. 10.1093/mutage/gep053 · DOI · Paper page
  77. 10.1136/thorax.57.9.759 · DOI · Paper page

Cited by

See all 53

Metadata

Authors
Alhariri, M., & Omri, A.
Affiliations
Novel Drug and Vaccine Delivery Systems Facility, Department of Chemistry and Biochemistry, Laurentian University, Sudbury, ON, Canada
Venue
Antimicrobial Agents and Chemotherapy
Published
2013-01
Volume
57
Issue
1
Pages
569-578
ISSN
  • 0066-4804
  • 1098-6596
Cited by
53
References
2
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection. https://app.cochat.ai/papers/10.1128/aac.01634-12
The paper
Alhariri, M., & Omri, A. (2013). Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01634-12

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.